187 related articles for article (PubMed ID: 29379479)
1. How Does HTLV-1 Undergo Oncogene-Dependent Replication Despite a Strong Immune Response?
Gazon H; Chauhan P; Hamaidia M; Hoyos C; Li L; Safari R; Willems L
Front Microbiol; 2017; 8():2684. PubMed ID: 29379479
[TBL] [Abstract][Full Text] [Related]
2. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus.
Sugamura K; Fujii M; Kannagi M; Sakitani M; Takeuchi M; Hinuma Y
Int J Cancer; 1984 Aug; 34(2):221-8. PubMed ID: 6088403
[TBL] [Abstract][Full Text] [Related]
3. Antigens on HTLV-infected cells recognized by leukemia and AIDS sera are related to HTLV viral glycoprotein.
Schüpbach J; Sarngadharan MG; Gallo RC
Science; 1984 May; 224(4649):607-10. PubMed ID: 6324349
[TBL] [Abstract][Full Text] [Related]
4. Effect of human serum anti-HTLV antibodies on viral antigen induction in vitro cultured peripheral lymphocytes from adult T-cell leukemia patients and healthy virus carriers.
Tochikura T; Iwahashi M; Matsumoto T; Koyanagi Y; Hinuma Y; Yamamoto N
Int J Cancer; 1985 Jul; 36(1):1-7. PubMed ID: 2862107
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of the gene expression of HTLV-I and its association with ATL.
Yoshida M; Fujisawa J; Inoue J; Seiki M
AIDS Res; 1986 Dec; 2 Suppl 1():S71-8. PubMed ID: 3030350
[TBL] [Abstract][Full Text] [Related]
6. Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses.
Oroszlan S; Copeland TD; Rice NR; Smythers GW; Tsai WP; Yoshinaka Y; Shimotohno K
Princess Takamatsu Symp; 1984; 15():147-57. PubMed ID: 6100635
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40x-responsive 21-base-pair sequence.
Jeang KT; Boros I; Brady J; Radonovich M; Khoury G
J Virol; 1988 Dec; 62(12):4499-509. PubMed ID: 3263510
[TBL] [Abstract][Full Text] [Related]
8. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
9. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
10. Envelope proteins of human T-cell leukemia virus: expression in Escherichia coli and its application to studies of env gene functions.
Kiyokawa T; Yoshikura H; Hattori S; Seiki M; Yoshida M
Proc Natl Acad Sci U S A; 1984 Oct; 81(19):6202-6. PubMed ID: 6091139
[TBL] [Abstract][Full Text] [Related]
11. Frequent lack of antibodies against human T-cell leukemia virus type I gag proteins p24 or p19 in sera of patients with adult T-cell leukemia.
Suetake N; Takeuchi Y; Shimizu N; Uesato H; Kuroume T; Hoshino H
J Cancer Res Clin Oncol; 1989; 115(3):279-84. PubMed ID: 2787798
[TBL] [Abstract][Full Text] [Related]
12. Complement-dependent cytotoxic antibodies to human T lymphotropic virus type I (HTLV-I)-infected cells in the sera of HTLV-I-infected individuals.
Plotnicky-Gilquin H; Afani A; Vernant JC; Desgranges C
Clin Exp Immunol; 1996 Jul; 105(1):39-45. PubMed ID: 8697633
[TBL] [Abstract][Full Text] [Related]
13. Detection of cross-reactive antibody to BLV p24 in sera of human patients infected with HTLV.
Onuma M; Tsukiyama K; Ohya K; Morishima Y; Ohno R
Microbiol Immunol; 1987; 31(2):131-7. PubMed ID: 2885727
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactive antibodies to BLV and HTLV in bovine and human hosts with retrovirus infection.
Maruyama K; Fukushima T; Mochizuki S
Vet Immunol Immunopathol; 1989 Oct; 22(3):265-73. PubMed ID: 2560858
[TBL] [Abstract][Full Text] [Related]
15. Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
Tezuka K; Okuma K; Kuramitsu M; Matsuoka S; Tanaka R; Tanaka Y; Hamaguchi I
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212930
[TBL] [Abstract][Full Text] [Related]
16. Activation of the human T-cell leukemia virus type I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate and by tax (p40x) occurs through similar but functionally distinct target sequences.
Radonovich M; Jeang KT
J Virol; 1989 Jul; 63(7):2987-94. PubMed ID: 2786091
[TBL] [Abstract][Full Text] [Related]
17. Human T-cell leukemia virus type-I/II (HTLV-I/II) serologic testing: the importance of assaying for the full complement of viral antigens.
Aboulafia DM; Bennett C; Koga H; Keith D; Slamon D
Viral Immunol; 1992; 5(2):105-11. PubMed ID: 1616582
[TBL] [Abstract][Full Text] [Related]
18. Human T-Cell Leukemia Virus Type 1 (HTLV-1) bZIP Factor Upregulates the Expression of ICAM-1 To Facilitate HTLV-1 Infection.
Fazio AL; Kendle W; Hoang K; Korleski E; Lemasson I; Polakowski N
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315993
[TBL] [Abstract][Full Text] [Related]
19. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood mononuclear cells from sheep infected with a variant of bovine leukemia virus synthesize envelope glycoproteins but fail to induce syncytia in culture.
Johnston ER; Powers MA; Kidd LC; Radke K
J Virol; 1996 Sep; 70(9):6296-303. PubMed ID: 8709257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
